Event Schedule

Event Schedule
With emphasis on getting to viable working relationships, all ASSETs events are carefully designed to provide the context and structure for extensive interaction between participants - by definition a highly dynamic process. With the schedule ever a Work-in-Progress, therefore, program additions, some re-definition of sessions and time-tweaking will likely continue until a few days before the event convenes.
WEDNESDAY September 21, 2011  
Time Session Title and Description
11:00 AM
On-site Registration and Package Pick-up
Light lunch is served: As a courtesy to participants who will have traveled in that morning and may not have had time to get lunch, a simple soup/ salad/ make-your-own sandwich buffet is available
Set-up of Poster Exhibits:  Scheduled as an integral part the FIVE-minute Nutshell presentation by all participating SBIR awardees, these will be initially located in the Skylane Suite.  They will be moved by Event Staff as necessary throughout the proceedings.

Conference begins: This later-than-usual event start is usefully designed to ease travel arrangements, to limit extent of out-of-office time and incurred accommodation costs.
 12:00 PM Informal Luncheon
1:00 PM Welcoming remarks: Overview of Novartis and Novartis OTC
Speaker Michael Kopcha, VP and Global Head, Global Product Development, Novartis Consumer Health
Format: Context setting presentation
1:35 PM SBIR as an engine for innovation
Speaker Ann Eskesen, Innovation Development Institute Format: Context setting presentation
  • Overview of SBIR - background etc.
  • Discussion of the range of options available to work with SBIR involved firms - i.e. to underscore that this is not just about the discrete bounded activities of licensing or buying product
  • Doing the numbers to include a useful look at the extent and form of SBIR involvement by Novartis:  

               • Corporate VC  • Acquisitions  • Partnering etc

2:05 PM Factors driving large firms to external collaborations as a means to fill capability gaps and to drive product innovation
Discussants Moderator: Ann Eskesen, Innovation Development Institute
Discussants:
Carl Ward, Category General Manager, New Growth Opportunities, Novartis OTC   
Marcus Chambers, Head, External Development, and Category Leader, Established Brands, Novartis Consumer Health, Geneva Switzerland
Joanne Hyland, Radical Innovation Group
Jan Twombly,  Rhythm of Business and ASAP (Association of Strategic Alliance Professionals)
Christine A. Carberry, Carberry Consulting, formerly Biogen Idec
Format:
Talk Show
Session is structured as free-wheeling, interactive discussion - far more like an at-the-dinner-table conversation of experienced players than a panel session with prepared presentations. Grounded in actual case experience and involving discussants with considerable large firm-small firm relationship experience.
2:50 PM Refreshment beak
3:15 PM Engaging the tools of market research to understand consumer needs and as a guide to product development
Speaker Carl Ward, Category General Manager, New Growth Opportunities, Novartis OTC Format: Context setting presentation
3:45 PM Tech Seeker overviews: Setting in context what interest Novarts Consumer Health
Speaker:
Gordon Dawson, Category Leader - Pain (Analgesics)
Format:  presentation
Speaker:
Emily Lesica, Category Leader -  Cough/Cold
Format: presentation
Speaker:
Ammunje Nayak, Category leader - Digestive Health
Format: presentation
Speaker:
Lance Shaw, Category Leader - New Growth Opportunity
Format: presentation
Speaker: Marcus Chambers, Head of External Development and Global Product Development for Established Brands Format: presentation
To lay the groundwork for substantive discussion in their areas of interest, each panelist will briefly address
  • Trends and issues in their space  
  • Factors that are driving external outreach
  • What would they see as success factors

Balance of the session will address the background issues common to all of the therapeutic areas.

4:40 PM
First set of In-A-Nutshell Presentations
Offered at various times throughout the Event, these FIVE minute presentations by invited SBIR Awardees synopsize the Capability Statement of the firm.  Presenters will have had pre-event opportunity to select their time slot.
  • Submitted Nutshells from all presenting firms will be on the custom-prepared Event USB Thumb Drive included in the Event Package. 
  • An alphabetized listing of all Presenting SBIR Awardees to include a brief statement of their areas of expertise, will be available in hard copy - called the Green Sheets - included in the Event Package.
  • All presentations will be audiotaped and, post-event, will be available for download from the Event Site
Individual time allocations strictly enforced
Timekeeper:
     Scott Silva, Innovation Development Institute
Presenting firms in order:
     Maria Stecklein Flynn,  Orbis Biosciences, Inc., Kansas City, KS
     Kenneth Narducy, St. Charles Pharmaceuticals, Inc., New Orleans, LA
     Gerard Housey, Housey Pharmaceutical Research Labs, Southfield, MI
     William Purcell, Molecular Design International, Inc., Memphis, TN
     Mark Geisberg, Silver Lake Research Corporation, Monrovia, CA
     Jane Nichols, Nanocopoeia, Inc., St. Paul, MN
     Maureen Mulvihill, Actuated Medical, Inc., Bellefonte, PA
     Phyllis Siegel, Biomedical Development Corporation, San Antonio, TX
     Terry Minton,  Naprogenix, Inc., Lexington, KY
     Jeff Williams, Lucigen Corporation, Middleton, WI
5:45 PM
Sub-Set of Poster Exhibit area Opens
Private viewing by interested Tech Seekers of those Posters specific to just-completed set of SBIR Awardee Nutshell
    Immediately following each set of Nutshell presentations, in space set-aside for the purpose and separate from the rest of the group, this period of time is allocated to enable private interaction between that set of awardees and interested Tech Seekers

6:00 PM
Gala Reception
Reception and Dinner opened for all Other Attendees with Presenters to join as they are able
7:30 PM
Day's Formal Program Concludes
THURSDAY, September 22, 2011
 
7:30 AM
Enhanced Continental Breakfast
 8:30 AM
Welcoming remarks
Speaker
Michael Kopcha, Vice President, Global Product Development, Novartis Consumer Health
 8:40 AM
New pathways to growth: Novartis OTC and SBIR
Speaker Joanne Hyland, Radical Innovation Group Format: Analytical presentation
SBIR companies and large, established companies are at very different phases in their organizational existence.
    •  SBIR-involved companies are looking for means to transition what they have from technology development to commercial success. Yet, by the very nature of their in-house business skill-sets, stage of development and limited access to resources, these companies often lack the scalability it takes to grow into a stand-alone business.

  • Large companies - such as Novartis OTC - in contrast are focused on protecting and growing their existing market and customer base while at the same time finding new pathways to growth. 
  • For each party, what the other offers potentially fills the void.
  • For the small firm partnering with the larger entity provides some of those critical resources        
  • While, for the larger firms. SBIR-funded companies offer an attractive solution for more strategic growth.

     The inherent dilemma lies in the fact that there exists a major gap between the entrepreneurial model required for a technology startup company and the efficient systems in place in a large firm to support the status quo.      
            Enabling the worlds of innovation and operational excellence to co-exist within a Novartis OTC and learning how to develop and nurture a symbiotic relationship with SBIR companies is critical to drive more significant growth.  This session will focus on answering the following questions:

  1. What are the cultural differences that need to be understood?
  2. What are the right questions Novartis OTC and SBIR companies should be asking of each other to determine business potential?
  3. How do two dissimilar organizations learn to communicate and work effectively together?
9:10 AM
Preparing for success: building for long-term success the right way
Speaker Janice Twombly, Rhythm of Business and ASAP (Association of Strategic Alliance Professionals) Format: Analytical presentation
For most companies, it is no longer a question of whetheror not to collaborate but rather how to do it effectively.  For many major corporations - particularly in the Life Science space - external partnering may be, if not the most important element in maintaining sustainable     growth, certainly a major factor.
    •  Done well, the benefits to all parties can be substantial. 
    •  Done poorly, collaborative relationships waste resources, create unnecessary risks, and can seriously drain energies.
            Historically, more than half of collaborative relationships fail.  The data suggests that in major part this is not due to a failure of the technology but rather due to management-related issues.
            Analysis further suggets strongly that successful partnering is fundamentally anchored in how the relationships is set up and managed - a process and condition often quite different from those addressed in the original  “terms of the deal contract”.
            Doing things the right way to support success requires focus and attention throughout the lifecycle of the relationship. Issues to be addressed in this overview will include
 •    Understanding what makes innovating with a partner so different from going it alone
 •     Elements of the collaboration agreement that are critical for long-term success
 •     Essential steps to prepare the organization for truly collaborative relationships
9:40 AM
Second set of In-A-Nutshell Presentations
Offered at various times throughout the Event, these 5-8 minute presentations by invited SBIR Awardees synopsize the Capability Statement of the firm.  Presenters will have had pre-event opportunity to select their time slot.
  • Submitted Nutshells from all presenting firms will be on the Event USB stick included in the Event Package. 
  • An alphabetized listing of all Presenting SBIR Awardees to include a brief statement of their areas of expertise, will be available in hard copy - called the Green Sheets - included in the Event Package.
  • All presentations will be audiotaped and, post-event, will be available for download from the Event Site
Individual time allocations strictly enforced
Timekeeper:
     Scott Silva, Innovation Development Institute
Presenting firms in order:
     Paul Nahass, Aspen Aerogels, Inc., Northborough, MA
     Al Behar, PICS, Inc., Reston, VA
     Sara Johnson, Pro-Change Behavior Systems, Inc.,  West Kingston, RI
     Daniel Levendowski, Advanced Brain Monitoring, Inc., Carlsbad, CA
     Sumedha Jayasena,  SomaGenics, Inc., Santa Cruz, CA
     Gordon Hirschman, Infoscitex Corporation, Waltham, MA
     James D. Thacker, Therimunex Pharmaceuticals, Inc., Doylestown, PA
     Randy Sallee, P2D Bioscience, Cincinnati, OH
     Susan Harrington, Harrington Software Associates, Inc., Warrenton, VA
     Theodore Rosenthal, Systems Technology, Inc., Hawthorne, CA
     Thomas Piccariello, Synthonics, Inc., Blacksburg, VA
     Anthony Sterns, iRx Reminder, LLC., Akron, OH
10:55 AM
Sub-Set of Poster Exhibit area Opens - featuring Poster specific to Awardee Nutshells.Private viewing by Tech Seeker.
Refreshment Break for all Other Attendees
11:30 AM
Concurrent Tech Seeker Breakouts
Speaker Gordon Dawson, Category Leader - Pain,  Analgesics Format: presentation
Speaker Emily Lesica, Category Leader, Cough & Cold Format: presentation
Speaker Ammunje Nayak, Category Leader, Digestive Health Format: presentation
Speaker Lance Shaw, Category Leader, New Growth Opportunity Format: presentation
Speaker Marcus Chambers, Head of External Development and Global Product Development for Established Brands Format: presentation

Each Tech Seeker has complete autonomy re. how they use their breakout time. However, in this context we generally suggest a format which encourages exploratory general questions by the SBIR awardees with the focus of getting a better handle on what the Tech Seeker is looking really for.  The value of the group approach to this important effort is that someone else invariably will ask the question that had not yet occurred to you.
     SBIR attendees are reminded that this session is less about determining  'does my particular technology fit' as it is about providing you opportunity to achieve a better overall understanding of what the Tech Seeker has in mind; what is not of interest;  what has already been tried etc.
    It is our experience that discussion in these sessions also often moves to process - how decisions are made re. with whom they will work;  forms of working relationship that might be on the table; the sort of money available;  how IP is handled etc.

Targeted breakouts are open to any interested SBIR awardee. Be aware that each Tech Seeker has complete autonomy re. how they use their breakout time. However, in this context we generally suggest a format which encourages exploratory general questions by the SBIR awardees with focus on getting a better handle on what the particular Tech Seeker is looking really for.  The value of the group approach to this important effort is that someone else invariably will ask question(s) that had not yet occurred to you.           
            SBIR attendees are reminded that group session Breakouts are NOT designed to be the place to determine  ‘does my particular technology fit’.  That can occur in extensive one-to-one interactions happening throughout event.  Instead, group sessions are about providing opportunity to achieve a better overall understanding of what Tech Seeker has in mind;  what is not of interest;  what has already been tried etc.
            It is our experience that discussion in these sessions also often moves to process - how decisions are made re. with whom they will work; the forms of working relationship that might be on the table; the sort of money available;  how IP is handled etc.
            It is reasonable to assume that the each Category Leader at this event may well have quite different procedures, expectations etc. It is likely, therefore, that most awardees with cross-discipline capabilities may find themselve with difficult choices.  
            If you expect this to be the case, you are recomended/encouraged to have more than one person fom the firm present at the event.
 12:30 PM
Luncheon: buffet style
 1:15 PM
After Lunch presentation: External partnering:  a perspective from the inside
Speaker Christine A. Carberry, Carberry Consulting, formerly VP, Program & Alliance Management at Biogen Idec Format: Issues based, voice of experience
The voice of experience coming from a professional alliance manger whose in-house job responsibility at a major corporation had involved the difficult, often complex and highly problematic task of operationalizing the deals others have made; and, in timely manner, to get the intended job done.
    The speaker for this session brings precisely this experience to the table for what promises to be a very thought-provoking session
1:45 PM
Relocate to Plenary session room: 
Third set of In-A-Nutshell Presentations
Offered at various times throughout the Event, these 5-8 minute presentations by invited SBIR Awardees synopsize the Capability Statement of the firm.  Presenters will have had pre-event opportunity to select their time slot.

  • Submitted Nutshells from all presenting firms will be on the Event USB stick included in the Event Package. 
  • An alphabetized listing of all Presenting SBIR Awardees to include a brief statement of their areas of expertise, will be available in hard copy - called the Green Sheets - included in the Event Package.
  • All presentations will be audiotaped and, post-event, will be available for download from the Event Site


Individual time allocations strictly enforced
Timekeeper:
     Scott Silva, Innovation Development Institute
Presenting firms in order:
     Mitchell Sanders,  ECI Biotech, Inc., Worcester, MA
     Gary Fujii,  Molecular Express, Inc., Rancho Dominguez, CA
     Trevor Castor, Aphios Corporation, Woburn, MA
     Luis Nunez, LNKChemsolutions, LLC., Denton, IL
     Kapil Pant, CFD Research Corporation, Huntsville, AL
     Simon McCarthy, HemCon Medical Technologies, Inc., Portland, OR
     Ioannis Tomazos, Biorasis, Inc., Mountain View, CA
     Thomas Parks, Osel, Inc., Storrs, CT
     Shuan S. Huang, Auxagen, Inc., Saint Louis, MO
     Presenter's name:  Name of firm, City, State

 2:45 PM
Sub-Set of Poster Exhibit area Opens
Private viewing by Tech Seekers
    As with the earlier groups of Nutshell presenters, this period will feature the Poster specific to the just-completed set of SBIR Awardee Nutshells. With an off-repeated underscore that this is non-proprietary content, participant will be any Novartis personnel who have follow-up technical questions to ask of the small firms they have just heard speak.
                        Refreshment Break for all Other Attendees
 3:15 PM
Search and Evaluation processes and Intellectual Property
Discussants
Barry Cohen, Head, Innovation
Frank Smith,
Global Head, OTC Patent
Joe Kiely,
Director, Search and Evaluation
Kelley Dealhoy, Vice President, Business Development & Licensing, Novartis Consumer Health
Format: Working discussion
Involving senior persons in this space, this session will take an in-depth look at the important underlying issues in how the Search and evaluation processes of Novartis OTC are structured.  Of particular emphasis will be how does Novartis OTC handle Intellectual Property that is

  • brought to the table by external sources     
  • as well as that which may be developed while in working relationship with Novartis

Moderator: Ann Eskesen, Innovation Development Institute

4:15 PM Concluding Remarks
Michael Kopcha, Vice President Global Product Development, Novartis Consumer Health
4:30 PM
Networking Reception
Formal conference activities conclude